PDT Partners’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-135,819
| Closed | -$972K | – | 783 |
|
2024
Q2 | $972K | Buy |
+135,819
| New | +$972K | 0.09% | 338 |
|
2023
Q4 | – | Sell |
-134,451
| Closed | -$1.34M | – | 626 |
|
2023
Q3 | $1.34M | Buy |
134,451
+35,484
| +36% | +$355K | 0.17% | 200 |
|
2023
Q2 | $1.23M | Sell |
98,967
-8,143
| -8% | -$101K | 0.17% | 200 |
|
2023
Q1 | $1.5M | Buy |
+107,110
| New | +$1.5M | 0.2% | 180 |
|
2022
Q3 | – | Sell |
-22,029
| Closed | -$626K | – | 992 |
|
2022
Q2 | $626K | Buy |
22,029
+10,762
| +96% | +$306K | 0.06% | 543 |
|
2022
Q1 | $397K | Sell |
11,267
-2,035
| -15% | -$71.7K | 0.03% | 639 |
|
2021
Q4 | $557K | Sell |
13,302
-7,597
| -36% | -$318K | 0.04% | 498 |
|
2021
Q3 | $1.03M | Buy |
20,899
+4,100
| +24% | +$201K | 0.07% | 335 |
|
2021
Q2 | $701K | Buy |
+16,799
| New | +$701K | 0.05% | 445 |
|